Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: a case report.

Reynolds BC, Paton JY, Howatson AG, Ramage IJ.

Pediatr Transplant. 2008 Mar;12(2):228-31. doi: 10.1111/j.1399-3046.2007.00707.x.

PMID:
18307673
2.

Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.

Staskewitz A, Kirste G, Tönshoff B, Weber LT, Böswald M, Burghard R, Helmchen U, Brandis M, Zimmerhackl LB.

Transplantation. 2001 Mar 15;71(5):638-44.

PMID:
11292293
3.

Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil.

Gross DC, Sasaki TM, Buick MK, Light JA.

Transplantation. 1997 Dec 15;64(11):1607-9.

PMID:
9415567
4.

Pulmonary fibrosis secondary to administration of mycophenolate mofetil.

Morrissey P, Gohh R, Madras P, Monaco AP.

Transplantation. 1998 May 27;65(10):1414. No abstract available.

PMID:
9625032
5.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
6.

Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.

Tedoriya T, Keogh AM, Kusano K, Savdie E, Hayward C, Spratt PM, Wilson M, Macdonald PS.

J Heart Lung Transplant. 2002 Sep;21(9):976-82.

PMID:
12231368
7.

Mycophenolate mofetil without antibody induction in cadaver vs. living donor pediatric renal transplantation.

Ojogho O, Sahney S, Cutler D, Baron PW, Abdelhalim FM, Hasan SM, Concepcion W.

Pediatr Transplant. 2003 Apr;7(2):137-41.

PMID:
12654055
8.

Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.

Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J.

Transpl Int. 2003 Nov;16(11):820-7. Epub 2003 Jul 22.

9.

Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.

Cransberg K, Cornelissen M, Lilien M, Van Hoeck K, Davin JC, Nauta J.

Transplantation. 2007 Apr 27;83(8):1041-7.

PMID:
17452893
10.

Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome.

El Kabbaj D, Hassani M, Kadiri M, Mounach J, Ouhabi H, Haimeur C, Oualim Z.

Saudi J Kidney Dis Transpl. 2012 Jul;23(4):790-3. doi: 10.4103/1319-2442.98162.

11.

Polyoma virus-associated progressive multifocal leukoencephalopathy after renal transplantation: regression following withdrawal of mycophenolate mofetil.

Weber SC, Uhlenberg B, Raile K, Querfeld U, Müller D.

Pediatr Transplant. 2011 Mar;15(2):E19-24. doi: 10.1111/j.1399-3046.2010.01368.x. Epub 2010 Sep 29.

PMID:
20880091
12.

Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial.

Höcker B, Weber LT, Bunchman T, Rashford M, Tönshoff B; Tricontinental MMF Suspension Study Group.

Pediatr Transplant. 2005 Aug;9(4):504-11.

PMID:
16048604
14.

Mycophenolate mofetil-induced colitis in children.

Phatak UP, Seo-Mayer P, Jain D, Selbst M, Husain S, Pashankar DS.

J Clin Gastroenterol. 2009 Nov-Dec;43(10):967-9. doi: 10.1097/MCG.0b013e3181a8754d.

PMID:
19609219
15.

Therapeutic idiosyncrasy.

Sweet SC.

Pediatr Transplant. 2008 Mar;12(2):121-2. Epub 2007 Dec 16. No abstract available.

PMID:
18086249
16.

The use of mycophenolate mofetil suspension in pediatric renal allograft recipients.

Bunchman T, Navarro M, Broyer M, Sherbotie J, Chavers B, Tönshoff B, Birk P, Lerner G, Lirenman D, Greenbaum L, Walker R, Zimmerhackl LB, Blowey D, Clark G, Ettenger R, Arterburn S, Klamerus K, Fong A, Tang H, Thomas S, Ramos E.

Pediatr Nephrol. 2001 Dec;16(12):978-84.

PMID:
11793083
17.

Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection.

Butani L, Palmer J, Baluarte HJ, Polinsky MS.

Transplantation. 1999 Jul 15;68(1):83-6.

PMID:
10428272
18.
19.

Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?

Boddana P, Webb LH, Unsworth J, Brealey M, Bingham C, Harper SJ.

Clin Transplant. 2011 May-Jun;25(3):417-9. doi: 10.1111/j.1399-0012.2010.01255.x. Epub 2010 Apr 21.

PMID:
20438577
20.

Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.

Waiser J, Schötschel R, Budde K, Neumayer HH.

Am J Kidney Dis. 2000 Mar;35(3):E12.

PMID:
10692297
Items per page

Supplemental Content

Write to the Help Desk